Accelerates and de-risks R&D for companies in the food, nutraceutical, microbiome, and pharma industries by providing an AI-assisted microfluidics-based in vivo platform utilizing the C. elegans model for testing compounds efficiently and human-relevantly, while developing custom biological readouts and tech platforms.